Ticker Scorecard - ADPT Basics Company: Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.14B Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 3.33% Avg Daily Range (30 D): $0.24 | 3.57% Avg Daily Range (90 D): $0.22 | 3.81% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 1.09M Avg Daily Volume (90 D): 1.07M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 2,424 Avg Inst. Trade: $1.86M Avg Inst. Trade (30 D): $1.15M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.27M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 124.14K     News Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Dec 7, 2024 @ 11:30 PM Adaptive Biotechnologies Announces New Data at the... Source: Adaptive Biotechnologies Corporation Aug 15, 2024 @ 2:58 PM Laboratory-Developed Tests (LDTs) World Market For... Source: Researchandmarkets.Com Aug 13, 2024 @ 8:58 AM Hematologic Malignancies Testing Markets, 2023-203... Source: Researchandmarkets.Com Jul 19, 2024 @ 2:00 PM Agenus (AGEN) Tanks on Colorectal Cancer Study Int... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.34 $-.22 $-.31 Diluted EPS $-1.34 $-.22 $-.31 Revenue $ 177.28M $ 46.44M $ 43.19M Gross Profit $ 103.63M $ 29.77M $ 23.87M Net Income / Loss $ -195.35M $ -32.1M $ -46.25M Operating Income / Loss $ -199.78M $ -32.63M $ -47.32M Cost of Revenue $ 73.65M $ 16.67M $ 19.32M Net Cash Flow $ -50.57M $ -21.74M $ -11.4M PE Ratio